N,N-Dimethyl-1-dodecanamine
Names
[ CAS No. ]:
112-18-5
[ Name ]:
N,N-Dimethyl-1-dodecanamine
[Synonym ]:
dimethyl dodecyl amine
N-dodecyl-N,N-dimethylamine
lauryl dimethyl amine
ipl
EINECS 203-943-8
Adma12
1-(Dimethylamino)dodecane,DDA
N,N-Dimethyllaurylamine
1-(Dimethylamino)dodecane
N,N-Dimethyl-1-dodecanamine
N,N-Dimethyldodecan-1-amine
dodecyl-dimethylamine
12N1&1
rc5629
N,N-dimethyl-laurylamine
1-Dodecanamine, N,N-dimethyl-
ADAM-2
EmpigenABE
n-dodecyl dimethylamine
Adma 2
barlene125
DMA12
MFCD00008970
N,N-dimethyl-n-dodecylamine
Chemical & Physical Properties
[ Density]:
0.8±0.1 g/cm3
[ Boiling Point ]:
265.2±3.0 °C at 760 mmHg
[ Melting Point ]:
−20 °C(lit.)
[ Molecular Formula ]:
C14H31N
[ Molecular Weight ]:
213.403
[ Flash Point ]:
106.9±4.7 °C
[ Exact Mass ]:
213.245651
[ PSA ]:
3.24000
[ LogP ]:
5.91
[ Vapour Pressure ]:
0.0±0.5 mmHg at 25°C
[ Index of Refraction ]:
1.442
[ Storage condition ]:
-20°C
[ Water Solubility ]:
Negligible
MSDS
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- JR6600000
- CHEMICAL NAME :
- Dodecylamine, N,N-dimethyl-
- CAS REGISTRY NUMBER :
- 112-18-5
- LAST UPDATED :
- 199710
- DATA ITEMS CITED :
- 6
- MOLECULAR FORMULA :
- C14-H31-N
- MOLECULAR WEIGHT :
- 213.46
- WISWESSER LINE NOTATION :
- 12N1&1
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- Standard Draize test
- ROUTE OF EXPOSURE :
- Administration onto the skin
- SPECIES OBSERVED :
- Rodent - rabbit
- REFERENCE :
- 85JCAE "Prehled Prumyslove Toxikologie; Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 Volume(issue)/page/year: -,439,1986
- TYPE OF TEST :
- Standard Draize test
- ROUTE OF EXPOSURE :
- Administration into the eye
- SPECIES OBSERVED :
- Rodent - rabbit
- REFERENCE :
- 85JCAE "Prehled Prumyslove Toxikologie; Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 Volume(issue)/page/year: -,439,1986 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 84138 No. of Facilities: 21 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 21 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 84138 No. of Facilities: 49 (estimated) No. of Industries: 3 No. of Occupations: 3 No. of Employees: 1539 (estimated) No. of Female Employees: 469 (estimated)
Safety Information
[ Symbol ]:
GHS05, GHS07, GHS09
[ Signal Word ]:
Danger
[ Hazard Statements ]:
H302-H314-H410
[ Precautionary Statements ]:
P273-P280-P303 + P361 + P353-P304 + P340 + P310-P305 + P351 + P338-P391
[ Personal Protective Equipment ]:
Faceshields;full-face respirator (US);Gloves;Goggles;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter
[ Hazard Codes ]:
C:Corrosive
[ Risk Phrases ]:
R22;R34
[ Safety Phrases ]:
S26-S36/37/39-S45-S60-S61
[ RIDADR ]:
UN 2735 8/PG 2
[ WGK Germany ]:
2
[ RTECS ]:
JR6600000
[ Packaging Group ]:
III
[ Hazard Class ]:
8
[ HS Code ]:
2921199090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2921199090
[ Summary ]:
2921199090 other acyclic monoamines and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%
Articles
J. Proteome Res. 14 , 2906-14, (2015)
We report a straightforward strategy to comprehensively monitor signal transduction pathway dynamics in mammalian systems. Combining targeted quantitative proteomics with highly selective phosphopepti...
Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging.Small 10(24) , 5137-50, (2014)
The blood-brain barrier (BBB) remains a formidable obstacle in medicine, preventing efficient penetration of chemotherapeutic and diagnostic agents to malignant gliomas. Here, a transactivator of tran...
RGS19 converts iron deprivation stress into a growth-inhibitory signalBiochem. Biophys. Res. Commun. 464 , 168-75, (2015)
Iron chelation is a promising therapeutic strategy for cancer that works, in part, by inducing overexpression of N-myc downstream-regulated gene 1 protein (NDRG1), a known growth inhibitor and metasta...